Starget Pharma
About:
Starget Pharma develops a novel somatostatin-based targeted therapy platform.
Website: http://www.stargetpharma.com
Top Investors: Cancer Focus Fund
Description:
Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
Total Funding Amount:
$15.1M
Headquarters Location:
Ramat Hasharon, Tel Aviv, Israel
Founded Date:
2019-01-01
Founders:
Ronen Kalmanson, Sigal Kalmanson Cusnir
Number of Employees:
1-10
Last Funding Date:
2024-10-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai